Zeria

Alexion's Ultomiris shows promise in neuromyelitis optica spectrum disorder phase 3 trial

Regulatory submissions for Ultomiris for the treatment of NMOSD are currently under review with multiple health authorities, including in the US, EU and Japan, the company said in a statement.

AstraZeneca’s Imjudo/Imfinzi combination approved by FDA for unresectable liver cancer

Regulatory applications for Imjudo in combination with Imfinzi are currently under review in Europe, Japan and several other countries for the treatment of patients with advanced liver cancer based on the

Amgen completes acquisition of ChemoCentryx in deal worth $3.7bn

The treatment is also approved in major markets outside the US, including the EU and Japan.

Moderna’s Omicron BA.1 booster shows superior antibody response over Spikevax

The Omicron-adapted booster has also received authorisations in the UK, Europe, Australia, Canada, Japan, South Korea, Switzerland, Singapore and Taiwan to date.

Novavax’s COVID-19 vaccine candidate approved for emergency use by FDA as a booster

The vaccine is also available for use as a booster in adults 18 years and older in the EU, Japan, Australia, New Zealand, Switzerland and Israel.

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]